EASD 2020: Editorial Board conference highlights
Listen to Sanjay Kalra, John Wilding and Lori Berard reflecting on their research highlights of this year’s virtual 56th EASD Annual Meeting. Listen below or subscribe to this podcast on: Spotify | Apple Podcasts | Google Podcasts | Stitcher | TuneIn About the experts Sanjay Kalra Sanjay Kalra, MBBS MD DM (AIIMS New Delhi), is an endocrinologist based at Bharti Hospital, […]
EAN 2020 | Ongoing reporting supports long-term safety of ocrelizumab in MS
Stephen Hauser reports the ongoing safety data for ocrelizumab in patients with relapsing or primary progressive multiple sclerosis, including preliminary post-marketing experience of a small group of patients with COVID-19 (5:13).
EAN 2020 | Ocrelizumab benefits in MS extend to patients with previous treatment failure
Bianca Weinstock-Guttman presents the 2-year CHORDS study findings showing good outcomes among patients with relapsing-remitting multiple sclerosis receiving ocrelizumab after a suboptimal response to previous disease-modifying therapy (3:17).
